Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Beigene, Biontech, Cstone, Dyne, Fresenius Kabi, G1, Moderna, Neurophth, Novavax, Pfizer, Prescient, Rznomics, SCG Cell Therapy, Sinovac, SK.